Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001711218 | SCV000057426 | benign | not provided | 2019-06-10 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000220386 | SCV000270777 | likely benign | not specified | 2016-01-29 | criteria provided, single submitter | clinical testing | p.Thr330Thr in exon 9 of PTPN11: This variant is not expected to have clinical s ignificance because it does not alter an amino acid residue and is not located w ithin the splice consensus sequence. It has been identified in 2/11546 Latino an d 2/8650 East Asian chromosomes by the Exome Aggregation Consortium (ExAC, http: //exac.broadinstitute.org; dbSNP rs369739920). |
Prevention |
RCV000220386 | SCV000309218 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000220386 | SCV000698088 | likely benign | not specified | 2020-08-30 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000033521 | SCV000776919 | likely benign | RASopathy | 2024-01-05 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001711218 | SCV002049688 | likely benign | not provided | 2023-10-23 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001813253 | SCV002060829 | uncertain significance | Noonan syndrome and Noonan-related syndrome | 2018-05-01 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000220386 | SCV002068880 | likely benign | not specified | 2018-04-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002381281 | SCV002694587 | likely benign | Cardiovascular phenotype | 2019-09-20 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
KCCC/NGS Laboratory, |
RCV003315538 | SCV004017224 | benign | Juvenile myelomonocytic leukemia | 2023-07-07 | criteria provided, single submitter | clinical testing |